Tissue perfusion is a critical parameter in validating tissue viability. Reduced perfusion is associated with clinical complications in acute and chronic tissue conditions in many clinical areas e.g. dermatology, wound care, open- and minimally invasive surgery.
Poor tissue viability decreases healing rates and speed of recovery while increases morbidity and mortality and thereby negatively impact the overall health economic cost.
The team behind Project Curiosity has developed a unique handheld laser speckle imaging (LSI) solution that can visualize blood perfusion in tissue. The intelligent and patented motion correction software algorithm makes it possible, for the first time, to perform high quality, handheld blood perfusion measurements and visualization. Can be used as a point of care either as a stand-alone device or integrated into other systems.
Unique selling points
- Omnipresent, easily accessible and flexible perfusion visualization
- Monitoring and perfusion measurement instantly and over time
- Data analyzing, storage and documentation for easy patient monitoring
- Prediction of clinical outcomes and reducing complications
The overall market potential for tissue viability validation is growing fast, driven by increasing clinical market needs and new technological solutions becoming available.
The overall market for perfusion imaging is expected to reach $ 12.03 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 8.2 % during 2017-2023.*
*Source: MarketResearchFuture.com: “Perfusion Imaging Market – 2018 Global Analysis, Growth, Trends and Opportunities Research Report forecasting to 2023”.
Dianova´s motion corrected LSI technology, in the concept of a handheld device, taps into a large and growing market within perfusion imaging with an estimated $1B global market potential.
Key opinion leaders and doctors show high interest in the concept of easy and fast tissue validation.
Due to its ease of use and handheld presentation. This new solution has the potential to open up the existing market and add new clinical use cases, which is currently out of reach with the current more expensive and bulky systems.